Andrea B. Apolo, M.D.

Andrea B. Apolo, M.D.
Investigator
Genitourinary Malignancies Branch
Head, Bladder Cancer Section
NIH Lasker Clinical Research Scholar

Dr. Apolo is dedicated to improving the treatment and survival of patients with genitourinary tumors. Her research involves developing and designing clinical trials to test novel agents for the treatment of urologic cancers. Her primary research interest is in bladder cancer (urothelial carcinoma) and prostate cancer. In particular, she is working to develop new bladder cancer therapies that use targeted agents including anti-angiogenesis compounds, which block the growth of new blood vessels that feed tumors. Other research focuses include improving tumor detection by using new imaging modalities in bladder and prostate cancer and identifying molecular alterations in bladder tumors that will serve as targets for individualized treatment strategies in patients with this disease. Dr. Apolo is fluent in both English and Spanish.

Appointments: Laura D. Otten, RN, BSN, OCN (301) 451-1228 or toll-free 1-866-611-6310

Areas of Expertise
1) bladder cancer, 2) genitourinary tumors, 3) clinical trials

Contact Info

Andrea B. Apolo, M.D.
Center for Cancer Research
National Cancer Institute
Building 10 - Magnuson Clinical Center, Room 13N240
Bethesda, MD 20892
Ph: 301-480-0536
Fax: 301-480-8867
andrea.apolo@nih.gov
Get Vcard
Permalink

Dr. Apolo is dedicated to improving the treatment and survival of patients with genitourinary tumors. Her research involves developing and designing clinical trials to test novel agents for the treatment of urologic cancers. Her primary research interest is in bladder cancer (urothelial carcinoma) and prostate cancer. In particular, she is working to develop new bladder cancer therapies that use targeted agents including anti-angiogenesis compounds, which block the growth of new blood vessels that feed tumors. Other research focuses include improving tumor detection by using new imaging modalities in bladder and prostate cancer and identifying molecular alterations in bladder tumors that will serve as targets for individualized treatment strategies in patients with this disease. Dr. Apolo is fluent in both English and Spanish. Appointments: Laura D. Otten, RN, BSN, OCN (301) 451-1228 or toll-free 1-866-611-6310

Scientific Focus Areas:
Cancer Biology, Clinical Research
View Dr. Apolo's PubMed Summary.

Selected Recent Publications

  1. Cabozantinib-induced thyroid dysfunction: a review of two ongoing trials for metastatic bladder cancer and sarcoma.
    Yavuz S, Apolo AB, Kummar S, Del Rivero J, Madan RA, Shawker T, Reynolds J, Celi FS.
    Thyroid. 24: 1223-31, 2014. [ Journal Article ]
  2. Everything old is new again! Neoadjuvant chemotherapy in the treatment of muscle-invasive bladder cancer.
    Sternberg CN, Apolo AB.
    J. Clin. Oncol. 32: 1868-70, 2014. [ Journal Article ]
  3. Examining the management of muscle-invasive bladder cancer by medical oncologists in the United States.
    Apolo AB, Kim JW, Bochner BH, Steinberg SM, Bajorin DF, Kevin Kelly W, Agarwal PK, Koppie TM, Kaag MG, Quinn DI, Vogelzang NJ, Sridhar SS.
    Urol. Oncol. 32: 637-44, 2014. [ Journal Article ]
  4. Multimodal management of muscle-invasive bladder cancer.
    Park JC, Citrin DE, Agarwal PK, Apolo AB.
    Curr Probl Cancer. 38: 80-108, 2014. [ Journal Article ]
  5. Neoadjuvant chemotherapy use in bladder cancer: a survey of current practice and opinions.
    Cowan NG, Chen Y, Downs TM, Bochner BH, Apolo AB, Porter MP, La Rochelle JC, Amling CL, Koppie TM.
    Adv Urol. 2014: [Epub ahead of print], 2014. [ Journal Article ]

Dr. Apolo is a graduate of Albert Einstein College of Medicine in New York. She completed clinical training in internal medicine at New York-Presbyterian Hospital/Weill Cornell Medical Center. Following her residency, she completed a medical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. Apolo joined the Medical Oncology Branch of the National Cancer Institute as an assistant clinical investigator. She is board certified for the practice of internal medicine and medical oncology and is a participating member of the American Society for Clinical Oncology.

Name Position
Rene Costello Medical Technologist
Deneise C. Francis RN, OCN, CCRP Research Nurse Specialist
Gloria L. Jackson MSN, CRNP, AOCNP Nurse Practitioner (Contr)
Elizabeth A. Lamping RN, BSN Research Nurse Specialist
Camera on Cancer Research: Attacking Bladder Cancer on Multiple Fronts
Treating Bladder Cancer: From Primary Tumor to Metastasis